Manufacturer record
Infinitive Pharmaceutical Industries: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Infinitive Pharmaceutical Industries (Gujarat) were declared Not of Standard Quality between December 2021 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 42675, Paracetamol Tablets IP 500mg (exp Mar 2027). RDTL, Bellary, Karnataka (state lab) found it not of standard quality: Dissolution. Listed in the May 2026 alert.
Records by type
2 records linked to Infinitive Pharmaceutical Industries in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol Tablets IP 500mg | Batch 42675Mfg Apr 2025 · Exp Mar 2027 | DissolutionDissolution | RDTL, Bellary, KarnatakaState lab | May 2026 |
| RESENT (Ondansetron HCl Tablets I.P. 4 mg) | Batch 3233Mfg Jun 2021 · Exp May 2023 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Dec 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.